Our top pick for
Anterix Inc is a telecom services business based in the US. Anterix shares (ATEX) are listed on the NASDAQ and all prices are listed in US Dollars. Anterix employs 58 staff and has a trailing 12-month revenue of around USD$1.2 million.
|Latest market close||USD$36.44|
|52-week range||USD$28.25 - USD$57.75|
|50-day moving average||USD$31.6018|
|200-day moving average||USD$39.0483|
|Wall St. target price||USD$65|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||USD$-2.667|
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-01-09)||N/A|
|1 month (2020-12-18)||23.65%|
|3 months (2020-10-16)||1.93%|
|6 months (2020-07-17)||-16.40%|
|1 year (2020-01-17)||-24.19%|
|2 years (2019-01-18)||-8.28%|
|3 years (2018-01-18)||5.47%|
|5 years (2016-01-16)||N/A|
|Revenue TTM||USD$1.2 million|
|Gross profit TTM||USD$431,000|
|Return on assets TTM||-11.12%|
|Return on equity TTM||-21.22%|
|Market capitalisation||USD$692.6 million|
TTM: trailing 12 months
There are currently 956,997 Anterix shares held short by investors – that's known as Anterix's "short interest". This figure is 2.5% up from 933,204 last month.
There are a few different ways that this level of interest in shorting Anterix shares can be evaluated.
Anterix's "short interest ratio" (SIR) is the quantity of Anterix shares currently shorted divided by the average quantity of Anterix shares traded daily (recently around 118440.22277228). Anterix's SIR currently stands at 8.08. In other words for every 100,000 Anterix shares traded daily on the market, roughly 8080 shares are currently held short.
However Anterix's short interest can also be evaluated against the total number of Anterix shares, or, against the total number of tradable Anterix shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Anterix's short interest could be expressed as 0.05% of the outstanding shares (for every 100,000 Anterix shares in existence, roughly 50 shares are currently held short) or 0.0801% of the tradable shares (for every 100,000 tradable Anterix shares, roughly 80 shares are currently held short).
A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Anterix.
Find out more about how you can short Anterix stock.
We're not expecting Anterix to pay a dividend over the next 12 months.
Over the last 12 months, Anterix's shares have ranged in value from as little as $28.25 up to $57.75. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Anterix's is 0.4315. This would suggest that Anterix's shares are less volatile than average (for this exchange).
Anterix Inc. operates as a wireless communications company. The company focuses on commercializing its spectrum assets to enable the targeted utility and critical infrastructure customers to deploy private broadband networks, technologies, and solutions. It holds licensed spectrum in the 900 MHz band with nationwide coverage throughout the United States, Hawaii, Alaska, and Puerto Rico. The company was formerly known as pdvWireless, Inc. and changed its name to Anterix Inc. in August 2019. Anterix Inc. was incorporated in 1997 and is headquartered in Woodland Park, New Jersey.
Everything we know about the Cloopen Group Holding Limited IPO, plus information on how to buy in.
Everything we know about the Decipher Biosciences Inc IPO, plus information on how to buy in.
Everything we know about the Proterra IPO, plus information on how to buy in.
Everything we know about the Grab IPO, plus information on how to buy in.
Everything we know about the Deliveroo IPO, plus information on how to buy in.
Everything we know about the Terns Pharmaceuticals Inc IPO, plus information on how to buy in.
Everything we know about the Angion Biomedica Corp IPO, plus information on how to buy in.
Everything we know about the PurposeBuilt Brands Inc IPO, plus information on how to buy in.
Everything we know about the Vor Biopharma Inc IPO, plus information on how to buy in.
Everything we know about the LumiraDx Limited IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.